High Vista Strategies LLC Bicycle Therapeutics PLC Transaction History
High Vista Strategies LLC
- $249 Million
- Q2 2024
A detailed history of High Vista Strategies LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, High Vista Strategies LLC holds 127,255 shares of BCYC stock, worth $3.15 Million. This represents 1.03% of its overall portfolio holdings.
Number of Shares
127,255
Previous 158,293
19.61%
Holding current value
$3.15 Million
Previous $3.94 Million
34.66%
% of portfolio
1.03%
Previous 1.56%
Shares
6 transactions
Others Institutions Holding BCYC
# of Institutions
110Shares Held
40.5MCall Options Held
3.4KPut Options Held
12.4K-
Baker Bros. Advisors LP New York, NY9.4MShares$233 Million2.53% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.49MShares$86.5 Million2.32% of portfolio
-
Ra Capital Management, L.P. Boston, MA2.25MShares$55.9 Million0.69% of portfolio
-
Fcpm Iii Services B.V. Naarden, P72.12MShares$52.6 Million6.34% of portfolio
-
Armistice Capital, LLC New York, NY1.97MShares$48.9 Million0.52% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $736M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...